13th January 2007
Life Expectancy for Children with Cystic Fibrosis should improve now that the new AIB Cystic Fibrosis Resource Centre has opened at Our Lady's Children?s Hospital, Crumlin. The good news was announced at the presentation of €210,000 from AIB towards the development of the centre. This brings to €317,430 the total funding provided by AIB to develop the unit and its construction has now been completed.
Cystic Fibrosis is the most common fatal hereditary disease in Ireland. It affects many organs in the body, particularly the lungs and digestive system. Children with the disease need daily chest physiotherapy and numerous medications.
Life expectancy for children in North America has dramatically improved in the last twenty years as a result of the development of specialised multi-disciplinary clinics - like the new one opened at Crumlin - that are specifically dedicated to the management of Cystic Fibrosis patients.
The AIB Cystic Fibrosis Resource Centre will offer a comprehensive CF management regime to children throughout the country through existing linkages between Our Lady's Hospital and paediatricians in all major and regional centres. Our Lady's Hospital is the ideal centre for this programme as it already has speciality paediatric services in the areas of respiratory medicine, gastroenterology, endocrinology, surgery and genetics that cannot be duplicated elsewhere in the country. At the new centre the children will be able to access a variety of services on the same day.
AIB supported this development as part of its Millennium Programme and the balance of the funding came from the Department of Health and The Children's Medical and Research Foundation at Our Lady's Hospital.
Eamonn Coghlan, Director of Fundraising & Development at The Children's Medical & Research Foundation said: "This is a very important development for Our Lady's Hospital. It will enable us to offer a world-class service to children with cystic fibrosis and their families and provide a centre where sufferers can benefit from the very latest treatments available. We're very grateful for AIB's very generous donation."
Brenda Moriarty, Head of Brand Management, AIB commented: "At AIB we're very happy to be able to support this new centre that we hope will make it possible for children with cystic fibrosis to live longer and healthier lives as well as improving the lives of their families. The new centre will provide world class care and therapies to these children that they can access on the same day, ensuring that they can carry on as normal a life as possible."